| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director +2 more
45 companies
Ra Capital Management, L.P. is a Director, 10% Owner at Wave Life Sciences Ltd. with holdings across 45 companies. Recent SEC Form 4 filings include 19 buys and 15 sells.
Estimated insider holdings value: $4519.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 6,510,416 | $11.52 | $74,999,992.32 | +74.9% | - | - | |
| May 11, 2026 | COAG Hemab Therapeutics Holdings, Inc. Common Stock | 10% Owner | Buy | 51,258 | $24.75 | $1,268,594.26 | +0.2% | - | - | |
| May 6, 2026 | COAG Hemab Therapeutics Holdings, Inc. Common Stock | Director, 10% Owner | Buy | 2,840,429 | $18.39 | $52,222,945.65 | +9.9% | - | - | |
| Apr 22, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 165,150 | $15.77 | $2,604,415.50 | -6.4% | +30.9% | - | |
| Apr 20, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 630,374 | $16.14 | $10,174,787.59 | -10.6% | +10.4% | - | |
| Apr 15, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 737,989 | $16.10 | $11,883,339.89 | -7.0% | +18.6% | - | |
| Apr 10, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 620,133 | $16.50 | $10,233,811.45 | -3.7% | +27.7% | - | |
| Apr 6, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 849,257 | $17.10 | $14,518,963.47 | -3.4% | +26.6% | - | |
| Mar 30, 2026 | WVE Wave Life Sciences Ltd. | Director, 10% Owner | Buy | 8,772,496 | $6.23 | $54,624,377.99 | +9.7% | -11.9% | - | |
| Feb 20, 2026 | ACET Adicet Bio, Inc. | 10% Owner | Buy | 223,596 | $7.17 | $1,603,934.13 | +7.2% | +10.5% | - |